Open-source AI predicts key peptide traits before costly lab testing
Penn Engineers have developed PeptiVerse, an AI-powered platform that predicts key chemical and biological properties of peptides, strings of amino acids whose medical potential has been demonstrated by the success of GLP-1 drugs, widely used weight-loss treatments.
Penn Engineers have developed PeptiVerse, an AI-powered platform that predicts key chemical and biological properties of peptides, strings of amino acids whose medical potential has been demonstrated by the success of GLP-1 drugs, widely used weight-loss treatments. This story matters for Science & Discovery readers tracking mech. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. MechNews curates and briefs the science & discovery stories that matter. Our editorial policy →